News

Despite Trade War, U.S. Drug Companies Turn to China for Key Cancer Treatments U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could ...
The stablecoin issuer began trading as the Trump administration is boosting the industry. Jack Daniel's maker Brown-Forman expects organic sales to decline this fiscal year as consumer demand softens ...
TMTPOST -- Nvidia Corporation on Tuesday reclaimed a crown as the world’s most valuable company amid strong shares rebound ...
After soaring in 2023 and 2024, shares of Tesla (NASDAQ:TSLA) was battered throughout Q1 2025. But since the start of Q2, the ...
The S&P 500 (^GSPC) logged its best May since 1990 and its best month since Nov. 2023, rising over 6%, while the Dow (^DJI) ...
Nvidia Corporation, the global leader in graphics processing units (GPUs) and artificial intelligence (AI) chips, delivered a ...
Tech stocks drag Nasdaq lower as soft PCE data boosts Fed rate cut hopes. Traders brace for June’s tariff rulings and policy ...
Nvidia earnings don’t do its quarter justice. The chip maker handled the loss of a massive business line and still generated ...
US Treasury Secretary Scott Bessent told Fox News on Thursday that trade talks between the US and China are "a bit stalled," ...
Despite Wall Street’s general approval of Nvidia’s results and outlook without China, Huang isn’t giving up on the region.
US stocks moved higher on Thursday as markets assessed Nvidia's earnings report as well as more tariff uncertainty.
Synopsys withdrew its outlook the July-ending quarter, disclosed after Wednesday's market close, which called for adjusted per-share earnings of $3.82 to $3.87 on sales of $1.76 billion to $1.79 ...